Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImperial Innovations Group Regulatory News (IVO)

  • There is currently no data for IVO

Directorate Changes

24 Oct 2014 07:00

RNS Number : 1755V
Imperial Innovations Group plc
24 October 2014
 



24 October 2014

 

Imperial Innovations Group plc

 

Directorate Changes

 

Imperial Innovations Group plc (AIM: IVO or 'the Group', 'Innovations') announces that its non-executive director Dr Paul Atherton will not be seeking re-election at the Group's AGM on 16 December 2014 and will step down from the Board as of that date.

 

Dr Atherton was appointed to the Board on 29 April 2006, having been a director of the Group's subsidiary Imperial Innovations Ltd since September 2004. Dr Atherton currently serves on the Nomination Committee of the Board and previously served on its Remuneration and Audit Committees.

 

Separately, in accordance with its policy of voluntary compliance with the UK Corporate Governance Code, the Group has appointed non-executive director Linda Wilding to the role of Senior Independent Director with immediate effect.

 

Martin Knight, Chairman of Imperial Innovations, said:

 

"On behalf of the Board I would like to thank Paul for his ten years of service, during which he has played an important and influential role in the evolution of the Group. His experience as a successful scientific entrepreneur and the chairman of technology businesses has ensured that the perspective of founders and managers remains central to our way of doing business.

 

"In addition to his role on the board of Innovations, Paul co-founded and chaired two of our spin-out companies. Midaz Lasers was successfully sold to Coherent Inc. in 2012, and Paul continues as the chairman of Nexeon, our largest unquoted investment.

 

"We look forward to continuing to work together with Paul and thank him for the significant contribution he has made to Innovations over many years."

 

For further information contact:

 

Imperial Innovations Group plc

020 3053 8834

Martin Knight, Chairman

Jon Davies, Director of Communications

 

Instinctif Partners

020 7457 2020

Adrian Duffield/Melanie Toyne-Sewell

 

J.P. Morgan Cazenove (Nominated Adviser)

020 7742 4000

Michael Wentworth-Stanley/Alec Pratt

 

Cenkos Securities

020 7397 8900

Andy Roberts/Christopher Golden

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAEAKEDASPLFFF
Date   Source Headline
10th Oct 20067:01 amRNSInvestment in InforSense Ltd
6th Oct 20067:01 amRNSNew Commercialisation Centre
3rd Oct 20069:35 amRNSHolding(s) in Company
29th Sep 200611:45 amRNSInvestment in Lontra Limited
25th Sep 20062:40 pmRNSInvestment in Midaz Lasers
11th Sep 20067:04 amRNSShareholding
5th Sep 20067:02 amRNSChief Investment Officer
21st Aug 20067:00 amRNSInvestment in Thiakis Limited
15th Aug 20063:34 pmRNSHolding(s) in Company
14th Aug 20067:04 amRNSLicensing Deal
14th Aug 20067:01 amRNSLicensing Agreement
9th Aug 200612:22 pmRNSHolding(s) in Company
1st Aug 20062:42 pmRNSHolding(s) in Company
31st Jul 20065:03 pmRNSDirector/PDMR Shareholding
31st Jul 20068:56 amRNSAdmission

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.